The post HYD Pioneers New Research Revealing Systemic Role of Deuterium-Depleted Water in Cancer Therapy appeared first on ...

When stem cells are injected into thick tissues, they often clump together and die from lack of oxygen or nutrients, making ...

Real-world data advances new insights into donor selection, benchmarks for patient infection prevention and comparative ...

Adoptive cell therapy (ACT) has emerged as a transformative approach in cancer immunotherapy, with remarkable clinical success in hematological ...

A recent study published in the International Journal of Molecular Sciences explores how deuterium concentration, an ...

A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...

The advisory has been issued based on the recommendations of the Indian Council of Medical Research (ICMR) ...

Commercialization ready compound supports a new method of generating highly functional human CAR-T cells for treating infectious diseases and cancer In experimental models, human CAR-T cells ...

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

The California Institute for Regenerative Medicine (CIRM) celebrates a major milestone in the agency’s 21-year history: the first approved therapy to come out of California taxpayer funding. The U.S.